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Abstract
Background: Little attention has been paid to quality improvement (QI) capacity within smaller primary care
practices which comprise nearly half of all primary care settings. Strategies for external support to build such
capacity include practice facilitation (PF), shared learning opportunities, and educational outreach. Although PF has
proven effectiveness, little is known about the comparative effectiveness of combining these strategies. Here, we
describe the protocol of the “Healthy Hearts Northwest” (H2N) study, a randomized trial designed to address these
questions while improving risk factors for cardiovascular disease.
Methods/design: The targeted enrollment is 250 smaller primary care practices across Washington, Oregon, and
Idaho. The study is utilizing a two-by-two factorial design to assess four different combinations of practice support: PF
alone, PF with educational outreach, PF with shared learning opportunities, or PF with both. A mixed methods
approach is being used for evaluation and will include data from (1) baseline and follow-up practice and staff surveys;
(2) baseline and quarterly clinical performance measurement from each practice on four cardiovascular risk factors:
appropriate aspirin use, blood pressure control, lipid management and smoking cessation support; and (3) a quality
improvement capacity assessment (QICA) survey used by external practice facilitators to guide improvement efforts.
Discussion: Results from this study will inform future large-scale practice improvement initiatives by providing
comparisons of promising external practice support strategies and advance our understanding of how to build QI
capacity in primary care.
Trial registration: ClinicalTrials.gov, NCT02839382
Keywords: Primary health care, Quality improvement, Cardiovascular diseases
Background
Cardiovascular disease (CVD) is a leading cause of
avoidable morbidity and mortality in the Unites States of
America (USA) [1]. The US Department of Health and
Human Services launched the “Million Hearts” initiative
in 2011 to prevent 1 million heart attacks and strokes by
2017 [2]. Within the primary care setting, the initiative
focuses improvement on four CVD risk factors, the
“ABCS”—aspirin use in high risk patients, blood pres-
sure control, cholesterol management, and smoking
cessation counseling. In 2015, the Agency for Healthcare
Research and Quality (AHRQ) launched the Evidence-
NOW initiative to both support improvement of these
CVD risk factors among patients within smaller primary
care practices across the USA and to advance the sci-
ence of building quality improvement (QI) capacity
within primary care [3].
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Although primary care is the foundation of health care
delivery in the USA, little attention has been paid to the
QI capacity of smaller primary care practices which
comprise nearly half of all primary care settings [4].
These smaller practices often lack the staffing and re-
sources to invest in the infrastructure and training that
provide essential elements of QI capacity [5, 6]. Even
when practices have resources and are committed to QI
in principle, they often struggle with developing and
implementing concrete strategies for making improve-
ment [7]. The potential impact of building QI capacity is
illustrated by the finding that twice as many deaths
could be prevented by optimized ABCS risk factor con-
trol within primary care compared to optimizing acute
cardiovascular care in the hospital setting [8].
Three specific external practice support strategies
stand out as promising approaches to build QI capacity
in primary care: practice facilitation (PF), shared learn-
ing opportunities, and educational outreach [7]. PF is
delivered by a facilitator, usually external to the practice
setting, who enables those who work within a practice
to implement a change in care delivery [9]. It is a
guided interactional process that has great potential
and demonstrated ability to support uptake and appli-
cation of scientific knowledge to improve clinical and
managerial decision-making [10]. There is substantial
evidence for the effectiveness of PF to support improve-
ment in primary care settings [11, 12]. Shared learning
opportunities, such as the learning collaborative approach
pioneered by the Institute for Healthcare Improvement,
can motivate change [13]. Educational outreach, often
called academic detailing, involves a trained outside expert
delivering one or more educational messages to a health-
care professional or the clinical team. It is generally
considered a promising method of modifying health pro-
fessional behavior, with a 5.6 % average improvement in
guideline concordant behavior from one large systematic
review [14].
Although PF alone has proven effectiveness to support
improvement, little is known about the benefit of supple-
menting this strategy with shared learning, educational
outreach, or both. This paper outlines the protocol of the
“Healthy Hearts Northwest” (H2N) study, a randomized
trial to build QI capacity in smaller primary care practices.
The primary aim of the study is to compare the effective-
ness of adding shared learning opportunities, educational
outreach, or both to PF for building QI capacity within
smaller primary care practices, with a focus on CVD risk
factor control. Our primary hypothesis is that the im-
provement in the ABCS clinical performance measures
will be greater among practices assigned to enhanced
practice support arms of the study compared to practice
facilitation alone, that practice capacity for QI will mediate
this relationship, and that external organizational support
and external climate for QI will moderate the observed
relationship between intervention arm and change in
ABCS outcomes. Our secondary hypothesis is that
compared to national control practices not participating
in the study, CVD clinical performance measures will
improve across all practices enrolled in H2N and this
improvement will vary across the different combinations
of practice support.
Methods
Study setting and recruitment
The study is taking place from May of 2015 to April of
2018 in smaller primary care practices across three
states: Washington, Oregon, and Idaho. H2N is a collab-
orative partnership between the MacColl Center for
Healthcare Innovation at the Group Health Research
Institute, Qualis Health in Washington and Idaho, the
Oregon Rural Practice Research Network (ORPRN)
based at the Oregon Health Sciences University, and the
University of Washington’s Institute of Translational
Health Sciences. Qualis Health is recruiting practices
and providing PF support in Washington and Idaho.
ORPRN is recruiting practices and providing PF support
in Oregon. The recruitment goal is 250 practices: 120 in
Washington, 100 in Oregon, and 30 in Idaho. To be eli-
gible, practices must have 10 full-time or fewer providers
in a single location and meet stage 1 electronic health
record (EHR) meaningful use criteria. Our rationale for
these priority criteria is to focus efforts on smaller prac-
tices with the greatest need for externally provided QI
expertise and have some capability to produce clinical
performance measure reports at the start of the study,
given the relatively short 36 months of funding.
Study design
A two-by-two factorial design is being used to compare
the effectiveness of adding shared learning opportun-
ities and educational outreach to PF. (Fig. 1) The four
factors (intervention arms) are (1) PF alone, (2) PF and
shared learning, (3) PF and educational outreach, and
(4) PF combined with both shared learning and educa-
tional outreach. In addition, a set of control data for
the ABCS clinical performance measures will be ob-
tained from a randomly selected national sample of
primary care practices not participating in the study.
This control data will consist of the four ABCS clinical
performance measures over the same historical time
period and reporting intervals as the practices enrolled
in the H2N study. Control practices will be matched
on practice size (clinician FTE), QI measure reporting
capabilities, and rural/urban location. This data will be
provided by the DARTNet Institute [15].
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Practice support interventions
PF support is provided to all sites upon enrollment in
the study for 15 months as a unifying approach. Two
enhanced practice support interventions, shared learning
through site visits and educational outreach on CVD
risk calculator use, are being offered to those practices
randomized to receive them over a period of 4 months
approximately 3–9 months after the start of the PF
support. A description of each type of external practice
support follows.
Practice facilitation and support
A geographic cluster of 10–20 practices are assigned to
each practice facilitator. Each practice is receiving
15 months of support with a minimum of five face-to-
face visits from the facilitator, with a monthly phone call
in-between the face-to-face visits. Additional phone or
video calls, emails, and text messaging are being pro-
vided as needed. A practice self-assessment tool (see
measures below) is used by the facilitator in the first
face-to-face visit to help the practice team achieve con-
sensus on their current status for each of eight change
concepts that build on prior practice transformation
work in small primary care practices [16]. These change
concepts provide direction to small practices in their
efforts to transform into true learning and improvement
organizations and comprise activities in the eight areas
as described in Table 1. More than a decade of work
by members of our team supports these concepts as
foundational to build practice capacity to learn and
improve [17, 18].
Shared learning opportunities through site visits
Practices randomized to the shared learning intervention
arm are offered the opportunity to visit an exemplar
practice with a particularly strong or innovative ap-
proach to QI. Exemplars are identified through nomina-
tions from facilitators and other members of the H2N
collaborative. They may or may not be practices enrolled
in H2N but must be within the three state geographic
region of the study. Exemplars are screened by phone
about their QI program and asked for reports on their
clinical performance measures. Practices randomized to
visit an exemplar receive support to coordinate the site
visit and travel reimbursement. Each exemplar practice
hosts 4–6 practices for a half-day visit within the 4-
month intervention period. The goal of the site visit is
to create an opportunity for practices to directly ob-
serve their QI approach and tools, examine work flows
and team member roles, and develop an on-going rela-
tionship with a practice that has an innovative ap-
proach to QI.
Educational outreach
The purpose of the academic educational outreach is to
encourage use of a CVD risk calculator or estimator [19]
within patient encounters. Current evidence-based clin-
ical guidelines support the use of such a risk estimator
to inform decisions about use of a statin medication to
manage CVD risk based on age, gender, smoking and
diabetes status, lipoprotein levels, and blood pressure
[20]. A small advisory group of full-time primary care
clinicians are developing the content of the educational
outreach program to address priority topics and issues.
The educational outreach will begin with a brief intro-
ductory video example of how a CVD risk estimator can
be integrated into a patient visit. This will be followed
by a 30-min phone call between each clinical team in
practices randomized to the intervention and a physician
academic expert. Each academic expert will be assigned
15 to 20 practices for a phone call.
Data collection and measures
Sources of data, measures, and variables are listed in
Table 2. A single practice-level survey and a survey com-
pleted by all clinicians and practice staff are administered
at baseline, 4 months after the period of the enhanced
practice support and 6 months after withdrawal of all prac-
tice support activities. The practice survey includes practice
demographics, information about health IT systems, and
Fig. 1 Factorial study design
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the Change Process Capacity Questionnaire (CPCQ), a
measure of the ability of an organization to manage change
processes [21]. The staff member survey includes the adap-
tive reserve scale, a measure of internal capability for
organizational learning and development [22].
CVD clinical quality measures (CQMs) on each of the
ABCS risk factors are being submitted by each practice
every 3 months with a 12-month look-back period for
each submission. Each practice submits a numerator and
denominator for each CQM every 90 days. Three of the
CQMs are based on definitions provided by the National
Quality Forum (NQF): NQF0068: ischemic vascular dis-
ease: appropriate use of aspirin/antithrombotic [23];
NQF0018: controlling high blood pressure [24]; and
NQF0028: preventive care and screening: tobacco use:
screening [25]. The original NQF cholesterol measure
proposed for the study is under revision based on recent
changes in evidence-based clinical guidelines. Instead,
we are requesting data from each practice on the pro-
portion of patients prescribed a statin who (a) have dia-
betes; (b) have a history of ischemic vascular disease; or
(c) in the absence of either condition have a low-density
lipoprotein (LDL) value greater than 190 mg/dl [26].
Practice capacity for QI activities are measured at two
time points by the quality improvement capacity assess-
ment (QICA) tool, a practice self-assessment tool used
by the facilitators to help practices identify areas where
change is needed to improve their capacity to engage in
QI. It is a modification of a previously validated tool
used to guide primary care practice transformation into
a medical home [16]. The single QICA for each practice
is completed by the practice team as a group during the
first face-to-face visit with their facilitator and again at
the fourth of the five face-to-face quarterly visits.
External organizational support for QI is reflected in
the growing influence of individual practice relationships
with other practices, hospitals, and healthcare systems.
Two questions on the practice survey are used to assess
this external organizational support: the degree to which
the practice is part of a larger organization with a
centralized QI team and the autonomy of the practice to
choose what QI projects they wish to work on.
External climate for QI is indicated by the state within
which the practice is located. Washington, Oregon, and
Idaho all provide unique state contexts and history with
primary care support, transformation, innovation, and
medical home work. For example, Oregon is currently a
site for the CMS/CMMI Comprehensive Primary Care
Initiative. Washington and Idaho both received a State
Innovation Model grant in 2014 from CMS. Idaho is
supporting primary care medical homes as part of their
SIM grant, but not Washington.
Qualitative data: We are using observation, interviews,
and field notes to describe how delivery of QI support
Table 1 Quality improvement change concepts and key activities
Change concept Description of practice activities
Embed clinical evidence
on ABCS into daily work
to guide care for patients
▪ Review the evidence supporting
the ABCS for primary and
secondary prevention of
cardiovascular risk
▪ Review treatment guidelines for
ABCS measures
▪ Educate staff on clinical guidelines
▪ Select patient education materials
for primary and secondary prevention
Utilize reliable, robust
data to understand and
improve ABCS measures
▪ Develop process to pull data from
EMR
▪ Review data for accuracy and build
confidence in data
▪ Develop process to support accurate
data entry/collection
▪ Use data to identify gaps between
the evidence-based guidelines and
current care for all patients on panel
▪ Create population-based reports and
visual data dashboards
Establish a regular QI
process involving
cross-functional teams
▪ Set aside regular meeting time for
cross-functional QI team
▪ Select a QI methodology to structure
improvement efforts
▪ Train team members on QI methodology
▪ Practice good meeting skills
▪ Regularly review data on ABCS outcome
and process measures to understand
areas for improvement




▪ Understand current patient panel relative
to ABCS
▪ Select actionable improvement goals
based on ABCS data
▪ Recall patients overdue for care/outreach




across the care team to
identify and manage
ABCS population
▪ Use workflow mapping to examine
current processes and explore other
approaches
▪ Introduce preventive screenings and
educational materials for ABCS measures
into workflow
▪ Develop/enable point of care reminders
based on ABCS guidelines
▪ Scrub charts daily to flag patients
needing support on ABCS
Deepen patient self-
management support for
action planning around ABCS
▪ Train staff in motivational interviewing
▪ Develop shared care plans with patients,
emphasizing goal setting led by patient
values







▪ Create list of community resources and
keep in a location accessible to all staff
members
▪ Outreach to community resources to
build referral pathway
▪ Provide list of resources to patients
▪ Proactively refer patients to community
resources and assist in establishing patient
with the resource
ABCS aspirin, blood pressure, cholesterol, smoking, EMR electronic medical
record, QI quality improvement
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through PF was tailored to individual practices, the in-
fluence of the external climate, as well as challenges,
success factors, and lessons learned. Practice facilitators
are keeping detailed notes after each contact with their
assigned practices including face-to-face visits, phone
calls, emails, and text messages. In addition to these field
notes, additional data are being collected through focus
groups with facilitators at training sessions, interviews
with experts in state level healthcare policy, and inter-
views with individual facilitators.
Randomization and data analysis
Randomization
We are using a stratified randomization with enrolled
practices categorized into one of six strata defined by PF
support organization (Qualis Health or ORPRN), prior
practice experience obtaining customized data to drive
improvement (yes, no), and prioritization of the work by
the practice (high, low). Information on the latter two
variables is collected in the baseline practice survey prior
to randomization. Within each stratum, practices are ran-
domly assigned by a computer-generated randomization
scheme to one of the four intervention arms developed by
the biostatistician. The evaluation/analysis team [AJC, RP,
AC] are blinded to assignment.
Data analysis
The primary aim of this study is to compare the effect-
iveness of adding shared learning opportunities, educa-
tional outreach, or both to PF on CQMs for each ABCS
risk factor by building QI capacity within each practice.
To address this aim, our primary outcome is the
practice-level blood pressure CQM covering the time
period 1-year after intervention uptake. Specifically, all
practices participating in the study are randomized to
one of four intervention groups in August 2016. We
define baseline ABCS CQMs as those covering the year
prior to randomization (July 1, 2015 to June 30, 2016)
(Fig. 2). After randomization, roll-out of the active inter-
vention arms occurs from September 2016 to December
2016. CQM data that covers this roll-out time period for
all intervention arms will not be used for outcome
assessment to allow for active intervention uptake (simi-
lar to a wash-out period in a standard cross-over ran-
domized trial). Our 1-year follow-up outcome measure
for our primary aim is the blood pressure CQM that
covers the 12-month time period after the intervention
roll-out period, from January 2017 to December 2017.
For the primary analysis to assess differences between
the four intervention groups on the primary outcome
practice-level proportion with blood pressure control at
1-year follow-up (blood pressure CQM), we will fit the
following linear regression model:
Y i ¼ β0 þ β1X1i þ β2X2i þ β3X3i þ βbaseY 0i þ βzZi




where Yi is clinics i blood pressure CQM at 1-year
follow-up, X1i, X2i, and, X3i are three indicator variables
Table 2 Measures and data sources
Construct Data source Measure(s) Timing




• Eight change concepts (see Table 1) Baseline and 9–12 months
after start of practice facilitation
Prior experience with QI Practice survey • Change process capacity
questionnaire (CPCQ) [21]





Practice survey • Is the practice is part of a large
organization with a centralized
QI team?
• The autonomy of the practice to
choose what QI projects they wish
to work on
Baseline and 4 months after
exposure to enhanced support
interventions
External climate for QI Practice survey • Location of practice: Washington,
Oregon, or Idaho
Baseline and 4 months after
exposure to enhanced support
interventions
Adaptive reserve Staff survey • Adaptive reserve scale [22] Baseline and 4 months after
exposure to enhanced support
interventions
Clinical quality measures
for ABCS CVD risk factors
Numerator and denominator report
generated by each practice from their
Electronic Health Record
• NQF0068: ischemic vascular disease:
appropriate use of aspirin/antithrombotic
• NQF0018: controlling high blood pressure
• NQF0028: preventive care and screening:
tobacco use
• CMS proposed statin measure
Every 90 days with a 12 month
look-back period
CVD cardiovascular disease; NQF National Quality Forum; QI quality improvement; ABCS aspirin, blood pressure, cholesterol, and smoking
Parchman et al. Implementation Science  (2016) 11:138 Page 5 of 9
for intervention assignment for site visit, educational
outreach, or both, respectively, Yi
0 is baseline blood
pressure CQM, and Zi is a vector of other baseline co-
variates to adjust for differences between clinics includ-
ing PF support organization (Qualis Health or ORPRN),
baseline prior practice experience obtaining customized
data to drive improvement (yes, no), and baseline
prioritization of the work by the practice (high, low). We
will use the Fisher’s protected least significant difference
approach to control for multiple comparisons due to the
comparison of four intervention arms. Specifically, we
will first calculate an Omnibus F test to assess if there
are any significant differences between intervention
groups and only calculate pairwise comparisons if this
omnibus test is statistically significant.
Our analyses will assume intention to treat principles
by treating intervention assignment as randomized
regardless of whether the intervention had uptake within
the practice. We will also attempt to obtain outcome
data for all practices even if they stop participating in
the intervention. However, there may be some practices
that drop-out and stop providing follow-up data. To
account for bias due to loss-of-follow-up, we will adjust
for baseline practice-level variables that we a priori
expect to be related to outcome and may be predictive
of loss-to-follow-up. Sensitivity analysis including last
value carry forward (follow-up outcome is the baseline
outcome for missing practice data) will also be con-
ducted. If loss-to-follow-up is large (>15 %), we will
further explore inverse probability of treatment weight-
ing or multiple imputation to handle missing outcome
data. We will further conduct subgroup analyses to as-
sess for differential intervention effects (moderators) by
baseline practice-level variables including PF support
organization, prior practice experience obtaining cus-
tomized data to drive improvement, prioritization of the
work by the practice (high, low), and adaptive reserve
(low, medium, and high). Similar analysis will be con-
ducted for secondary outcomes including the other
ABCS CQM measures and changes in practice variables
such as practice capacity QI.
If we find a difference between any of the four inter-
vention arms, we will conduct a mediator analysis to
assess if change in practice capacity for QI was a poten-
tial pathway for change in ABCS CQM outcomes.
Specifically, we will conduct a mediator analysis follow-
ing the Barron and Kenny framework [27]. Step 1 is to
show that the intervention had an effect of the follow-up
outcome. Step 2 is to show that the intervention was
associated with change in the potential mediator practice
capacity for QI. Step 3 is then to show that the interven-
tion effect is mediated or reduced once the mediator is
taken into account. For step 2, we will use a similar linear
regression model as outlined for the primary analyses, but
the outcome will be the mediator change in practice cap-
acity for QI. For step 3, we will use a similar linear model
as outlined for the primary analysis except now further ad-
just for the change in practice capacity for QI. We will use
the method of Sobel [28] to test for the mediator’s indirect
effect of the interventions on the ABCS CQM outcome.
A secondary aim of this study is to assess if PF alone im-
proves clinic-level ABCS outcomes (note that PF is given
to all practices in our randomized trial population). To
address this aim, we will conduct an observational study
using data from our randomized study practices and
control practices from the DARTNet Institute. Specific-
ally, we will have data on practice-level ABCS outcomes
1-year prior to PF roll-out in each of our randomized trial
practices and 1-year post PF roll-out. To control for
potential confounding, we will match each randomized
control trial practice to one or more control practices
matching on practice size (clinician FTE), QI measure
reporting capabilities as measures by their ability to gener-
ate a custom report without support from their EHR
vendor, and rural/urban location. For each matched pair,
we will use the same data ascertainment windows based
on when the randomized control trial practice had PF
rolled out. This will control for temporal changes. We will
conduct similar analyses as proposed for the randomized
trial except that now outcome time is tied to PF roll-out,
and we will only include a single intervention indicator
that had or did not have PF.
Fig. 2 Project timeline and data collection windows
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Sample size
The main aim of the trial is to assess if any of the
enhanced practice support arms (site visit, educational
outreach, or both) improved ABCS CQM outcome
performance relative to practices that received PF alone.
If one assumes a 20 % attrition rate over the life of the
study leaving 50 practices in each of the four interven-
tion arms, we have 80 % power to detect a 0.114 propor-
tion improvement in any of the three enhanced practice
support arms relative to PF for the 1-year practice out-
comes blood pressure CQM or aspirin CQM. We as-
sumed an outcome standard deviation of 0.26 for both
ABCS outcomes (based on baseline data from the en-
rolled practices) and a F test comparing the four inter-
vention arms assessing for any difference between
groups. Further, we used an adjusted sample size calcula-
tion for ANCOVA models [29] (proposed analysis
adjusts for baseline outcome) assuming a 0.60 correl-
ation coefficient between baseline outcome measure and
follow-up outcome measure. Even with an additional
10 % clinic attrition rate (45 practices per arm with
follow-up), we will have 80 % power to detect a differ-
ence of 0.121 in practice proportion improved in either
ABCS outcome. We conducted power calculations via
simulation using R version 3.0.2.
Trial status
At the time of manuscript submission, the study was
16 months into the 36 months of support from AHRQ.
The Group Health Research Institute’s Institutional
Review Board approved this study.
Discussion
Significance
While prior research identified promising approaches for
supporting primary care practice improvement in the
USA, there have been few comparative effectiveness
studies that rigorously assessed the combinations of the
external practice support interventions described here.
In a study that compared traditional learning collabora-
tive with PF to PF alone, the addition of a local learning
collaborative enhanced use of asthma guidelines [30]. In
addition, little is known about effective and efficient
approaches to support practice improvement across a
large geographic region with the number and diversity of
smaller primary care practices enrolled in Healthy
Hearts Northwest [31, 32].
Evaluations of the effectiveness of the traditional
“learning collaborative” approach to shared learning have
shown mixed results [33, 34]. Our unique approach to
shared learning through site visits is grounded in diffu-
sion of innovation theory on the premise that such visits
create opportunity to more directly observe QI ap-
proaches and understand how these can be adapted to a
practice’s own circumstances and setting [35]. Site visits
may also serve to alter informal peer social networks by
establishing or strengthening ties between individuals
across practices or clinics [36]. In one of the few studies
of the influence of a social network, Keating and col-
leagues demonstrated that physicians were more likely
to obtain information from colleagues with greater
expertise and experience [37].
The role of educational outreach in addition to prac-
tice facilitation and or shared learning activities is
largely unknown. Traditional educational outreach is a
one-on-one activity between an academic expert and
an individual clinician. In a study of group versus indi-
vidual academic detailing for use of antihypertensive
medications, both were equally more effective than
usual care practices in improving prescribing habits
[38]. For purposes of this study, we will be using edu-
cational outreach to help facilitate a major shift in the
way that the clinicians and their teams approach all
four ABCS risk factors by combining them into a single
CVD risk measure. The alternative is to conduct educa-
tional outreach for each individual ABCS measure separ-
ately. If successful, this shift in approach would be a
significant step forward in implementation methods.
Limitations
In addition to recruitment and retention barriers, poten-
tial limitations to building the QI capacity include a lack
of EHR resources needed to generate ABCS clinical
performance measures even though the system may meet
stage 1 EHR meaningful use criteria, no financial incen-
tives for investing in building QI capacity, and the
competing demands of the changing reimbursement en-
vironment such as implementation of the Medicare
Access and CHIP Reauthorization Act [39]. In addition,
disruptions such as implementing a new EHR, turnover in
practice leadership, changes in practice staffing, or prac-
tice acquisition by a larger healthcare organization pose
significant barriers to building high-functioning QI teams.
We will mitigate EHR limitations by providing spe-
cific consultations and technical assistance by infor-
mation technology experts from both Qualis Health
and the Oregon Health Sciences University. Practice
facilitators will work closely with their assigned practices
to assess additional opportunities to participate in other
practice transformation support initiative and assess their
synergy with the Healthy Hearts Northwest support as
well as maintaining trusting relationships with all mem-
bers of the practice team to assist them with disruptions
when they occur.
Impact
In addition to its impact on CVD across a large popula-
tion in the Pacific Northwest, the work of improving the
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capacity of smaller practices to engage in QI activities
will prepare them for the transition to value-based reim-
bursement. Our findings will also have broad implica-
tions for understanding the type of technical assistance
and support required to support smaller primary care
practices in a rapidly changing healthcare environment.
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